{"title":"Charlotte Jacobs","description":"\u003cp\u003e0\u003c\/p\u003e","products":[{"product_id":"henry-kaplan-and-the-story-of-hodgkin-s-disease-book-charlotte-jacobs-9780804768665","title":"Henry Kaplan and the Story of Hodgkin's Disease","description":"In the 1950s, ninety-five percent of patients with Hodgkin's disease, a cancer of lymph tissue which afflicts young adults, died. Today most are cured, due mainly to the efforts of Dr. Henry Kaplan. Henry Kaplan and the Story of Hodgkin's Disease explores the life of this multifaceted, internationally known radiation oncologist, called a \"saint\" by some, a \"malignant son of a bitch\" by others. Kaplan's passion to cure cancer dominated his life and helped him weather the controversy that marked each of his innovations, but it extracted a high price, leaving casualties along the way. Most never knew of his family struggles, his ill-fated love affair with Stanford University, or the humanitarian efforts that imperiled him.   Today, Kaplan ranks as one of the foremost physician-scientists in the history of cancer medicine. In this book Charlotte Jacobs gives us the first account of a remarkable man who changed the face of cancer therapy and the history of a once fatal, now curable, cancer. She presents a dual drama —the biography of this renowned man who called cancer his \"Moby Dick\" and the history of Hodgkin's disease, the malignancy he set out to annihilate. The book recounts the history of Hodgkin's disease, first described in 1832: the key figures, the serendipitous discoveries of radiation and chemotherapy, the improving cure rates, the unanticipated toxicities. The lives of individual patients, bold enough to undergo experimental therapies, lend poignancy to the successes and failures.   Please visit the author's website at www.charlottejacobs.net.","brand":"WoB","offers":[{"title":"US \/ GOOD \/ SBYB","offer_id":50367625101585,"sku":"CIN0804768668G","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"US \/ NEW \/ INGRAM","offer_id":51007695847697,"sku":"NIN9780804768665","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/0804768668.jpg?v=1757414437"},{"product_id":"90-seconds-to-midnight-book-charlotte-jacobs-9781640126305","title":"90 Seconds to Midnight","description":"90 Seconds to Midnight tells the gripping and thought-provoking story of Setsuko Nakamura Thurlow, a thirteen-year-old girl living in Hiroshima in 1945, when the city was annihilated by an atomic bomb. Struggling with grief and anger, Thurlow set out to warn the world about the horrors of a nuclear attack in a crusade that has lasted seven decades.   In 2015 Thurlow sparked a rallying cry for activists when she proclaimed at the United Nations, “Humanity and nuclear weapons cannot coexist.” With that, she shifted the global discussion from nuclear deterrence to humanitarian consequences, the key in crafting the landmark Treaty on the Prohibition of Nuclear Weapons. Regarded as the conscience of the antinuclear movement, Thurlow accepted the 2017 Nobel Peace Prize on behalf of the International Campaign to Abolish Nuclear Weapons. With the fate of humanity at stake and with the resolve of her samurai ancestors, Thurlow challenged leaders of the nuclear-armed states. On January 22, 2021, the Treaty on the Prohibition of Nuclear Weapons went into effect, banning nuclear weapons under international law.   Critical historical events need a personal narrative, and Thurlow is such a storyteller for Hiroshima. 90 Seconds to Midnight recounts Thurlow’s ascent from the netherworld where she saw, heard, and smelled death and her relentless efforts to protect the world from an unspeakable fate. Knowing she would have to live with those nightmares, Thurlow turned them into a force to impel people across the globe to learn from Hiroshima, to admit that yes, it could happen again-and then to take action.","brand":"WoB","offers":[{"title":"- \/ - \/ -","offer_id":51628119916817,"sku":"","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"US \/ NEW \/ INGRAM","offer_id":51628120178961,"sku":"NIN9781640126305","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ GARDNERS","offer_id":51628120244497,"sku":"NGR9781640126305","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/1640126309.jpg?v=1751152112"},{"product_id":"cancers-of-the-head-and-neck-book-charlotte-jacobs-9781461292081","title":"Cancers of the Head and Neck","description":"However, despite optimal treatment with surgery and radiotherapy, patients with nodal spread or extensive local disease have a low cure rate. New, creative methods of radiation therapy delivery, such as the use of multiple fractions per day, as discussed by Parsons and Million, are also contributing to long-term local control.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52127264571665,"sku":"NLS9781461292081","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781461292081.jpg?v=1757485290"},{"product_id":"carcinomas-of-the-head-and-neck-book-charlotte-jacobs-9781461288060","title":"Carcinomas of the Head and Neck","description":"It was not too many years ago that the role of chemotherapy for head and neck cancer consisted of single-agent methotrexate for selected patients with recurrent disease. In the past decade, multiple new agents, high-dose chemotherapy, combinations, and intra-arterial approaches have been used for the patient with recurrent disease. Wheeler critically assesses the current status of these approaches. When oncologists began testing chemotherapy in the combined modality approach, trials consisted of induction chemotherapy and use of single agents as radiosensitizers. Although a great deal has been learned from these trials, benefit in terms of survival has been marginal. Even more promising may be the concomitant use of combination chemo- therapy and radiation. Taylor describes the encouraging results as well as the potential. Induction chemotherapy may have a second important goal in addition to improving curability-it could be used for organ preservation. Dimery et al., present the background for this approach in the patient with laryngeal cancer as well as a description of their randomized trial for voice preservation. Head and neck squamous cancers are a heterogeneous group of diseases, and surgeons have long sought parameters that will help predict outcome.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52142323794193,"sku":"NLS9781461288060","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781461288060.jpg?v=1757579783"},{"product_id":"carcinomas-of-the-head-and-neck-book-charlotte-jacobs-9780792306689","title":"Carcinomas of the Head and Neck","description":"It was not too many years ago that the role of chemotherapy for head and neck cancer consisted of single-agent methotrexate for selected patients with recurrent disease. In the past decade, multiple new agents, high-dose chemotherapy, combinations, and intra-arterial approaches have been used for the patient with recurrent disease. Wheeler critically assesses the current status of these approaches. When oncologists began testing chemotherapy in the combined modality approach, trials consisted of induction chemotherapy and use of single agents as radiosensitizers. Although a great deal has been learned from these trials, benefit in terms of survival has been marginal. Even more promising may be the concomitant use of combination chemo- therapy and radiation. Taylor describes the encouraging results as well as the potential. Induction chemotherapy may have a second important goal in addition to improving curability-it could be used for organ preservation. Dimery et al., present the background for this approach in the patient with laryngeal cancer as well as a description of their randomized trial for voice preservation. Head and neck squamous cancers are a heterogeneous group of diseases, and surgeons have long sought parameters that will help predict outcome.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52143513403665,"sku":"NLS9780792306689","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780792306689.jpg?v=1757584823"},{"product_id":"cancers-of-the-head-and-neck-book-charlotte-jacobs-9780898388251","title":"Cancers of the Head and Neck","description":"However, despite optimal treatment with surgery and radiotherapy, patients with nodal spread or extensive local disease have a low cure rate. New, creative methods of radiation therapy delivery, such as the use of multiple fractions per day, as discussed by Parsons and Million, are also contributing to long-term local control.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52483888840977,"sku":"NLS9780898388251","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"US \/ NEW \/ INGRAM","offer_id":53558369583377,"sku":"NIN9780898388251","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780898388251.jpg?v=1759855432"},{"product_id":"henry-kaplan-and-the-story-of-hodgkin-s-disease-book-charlotte-jacobs-9780804785051","title":"Henry Kaplan and the Story of Hodgkin's Disease","description":"Henry Kaplan and the Story of Hodgkin's Disease is the first account of a remarkable man who changed the face of cancer therapy and the history of a once fatal, now curable, cancer.","brand":"WoB","offers":[{"title":"US \/ NEW \/ INGRAM","offer_id":52740171858193,"sku":"NIN9780804785051","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780804785051.jpg?v=1763481727"}],"url":"https:\/\/www.worldofbooks.com\/collections\/author-books-by-charlotte-jacobs.oembed","provider":"World of Books ","version":"1.0","type":"link"}